Literature DB >> 589346

Dopamine in cardiac failure and shock.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589346      PMCID: PMC1632740     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

Review 1.  Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.

Authors:  L I Goldberg; Y Y Hsieh; L Resnekov
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

Review 2.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

3.  Acute hemodynamic effects of dopamine in patients with shock.

Authors:  H S Loeb; E B Winslow; S H Rahimtoola; K M Rosen; R M Gunnar
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

4.  Hemodynamic studies and results of therapy in 50 patients with bacteremic shock.

Authors:  E J Winslow; H S Loeb; S H Rahimtoola; S Kamath; R M Gunnar
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

5.  Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.

Authors:  R Rosenblum; J Frieden
Journal:  Am Heart J       Date:  1972-06       Impact factor: 4.749

6.  Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.

Authors:  H S Loeb; J Bredakis; R M Gunner
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

7.  Comparison of dobutamine and dopamine in treatment of severe heart failure.

Authors:  J D Stoner; J L Bolen; D C Harrison
Journal:  Br Heart J       Date:  1977-05

8.  Hemodynamic effects of dobutamine in patients following open heart surgery.

Authors:  T Sakamoto; T Yamada
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

9.  Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease.

Authors:  R Rosenblum; A R Tai; D Lawson
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

10.  Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.

Authors:  R R Miller; N A Awan; J A Joye; K S Maxwell; A N DeMaria; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1977-06       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.